Lilly profit swells on success of new drugs
Eli Lilly and Co. profit grew 10 percent in the fourth quarter, to $986.4 million, on the strength of sales for its newer products. Sales of drugs including Cymbalta, Cialis, Alimta, Byetta and Forteo – all launched this decade – grew 30 percent in the quarter. Total sales grew 16 percent to $5.19 billion. The […]